Loading clinical trials...
Loading clinical trials...
A Phase 0, Open Label Study to Evaluate the Biodistribution and Pharmacokinetics of a Single Intravenous Bolus Dose of PTP-01 in Subjects With Resectable Pancreatic Ductal Adenocarcinoma
Conditions
Interventions
PTP-01
Locations
1
United States
University of Virginia
Charlottesville, Virginia, United States
Start Date
November 1, 2013
Primary Completion Date
January 1, 2016
Completion Date
January 1, 2016
Last Updated
March 18, 2016
NCT04657068
NCT06445062
NCT04900818
NCT07432633
NCT06005493
NCT04851119
Lead Sponsor
University of Virginia
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions